Seog-Woon Kwon, M.D.
Korean J Hematol 2011; 46(2): 59Jin Kyung Lee, M.D. Ph.D.
Korean J Hematol 2011; 46(2): 62-64Chul Hwan Lee
Korean J Hematol 2011; 46(2): 65-66Hye Ra Jung, Dong Seok Jeon, Keoun Uk Park, and Jung Sook Ha
Korean J Hematol 2011; 46(2): 67Harish Chandra, and Smita Chandra
Korean J Hematol 2011; 46(2): 68Ok S. Shin, and Jason B. Harris
Korean J Hematol 2011; 46(2): 69-79Chang-Ki Min
Korean J Hematol 2011; 46(2): 80-87Sang Hyuk Park, Hyun-Sook Chi, Sook-Kyung Min, Young-Uk Cho, Seongsoo Jang, Chan-Jeoung Park, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Ho-Joon Im, and Jong-Jin Seo
Korean J Hematol 2011; 46(2): 88-95Eun Sil Park, Hyery Kim, Ji Won Lee, Jae-Young Lim, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, and Hyo Seop Ahn
Korean J Hematol 2011; 46(2): 96-102
LMB 96 protocol schedule [8]. Patients were stratified into 3 risk groups: A, B, and C, depending on stage, resection status, percentage of blasts in BM, and CNS involvement. Group A: Resected stage I and abdominal stage II. Group B: Patients not eligible for inclusion in group A or C. Group C: Patient with CNS involvement and more than 70% of blast in bone marrow. In the LMB 96 protocol, cranial irradiation was skipped and replaced with high-dose methotrexate (MTX) between consolidation phases in patients with CNS-positive disease.
|@|~(^,^)~|@|Outcome in patients treated using the LMB protocol. Three patients showed relapse (RL) after complete response (CR), and 2 of them responded to salvage therapy and are alive with no evidence of disease. Cases that did not show CR after the first consolidation chemotherapy included 5 cases of partial response (PR) and 3 refractory (ref) cases. One case of toxic death occurred during induction chemotherapy.
|@|~(^,^)~|@|Survival outcome of patients treated using LMB 89 (1996-2007)
Event-free survival according to stage
Comparative analysis of event-free survival (EFS) according to the involvement of bone marrow. EFS of patients treated using the LMB protocol
Comparative analysis of event-free survival (EFS) according to the involvement of the central nervous system (CNS). EFS of patients treated using the LMB protocol